Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Alm Q4 Earnings Misses Estimates By 0.18 20260403 Lob A Stock Analysis Live Oak Bancshares 8.375 Series A Pref Flat At 100 Usd 20260403 Why Taiwan Semiconductor TSM Is Seen as a TopTier Company Key Factors Silo Pharma SILO Q4 2023 Disappoints EPS 036 Below 020 Views DeepSeek Concerns Overblown US AI Titans Pose Resilient Growth Industry Veteran Joins VCU to Transform Pharmaceutical Manufacturing Landscape Gas Prices Poised for Relief When Drivers Could See Lower Costs at the Pump Upwork UPWK Stock Analysis 600 Gain What to Watch 20260518 RCI RICK Q3 2025 Disappoints EPS 046 Below 126 Views Andy Burnham Seeks to Calm Markets with Fiscal Rules Commitment BlackRock Income Trust Inc BKT Edges Higher Amid Modest Gains Pelican PELIR Stock Today Rallies 508 Resistance at 087 20260520 Capital Banc CBNK Stock Slides 058 Support at 2952 20260521 Western WDI Stock Trend Sideways at 1337 Direction Unknown 20260521 Trump Invests Up to 5 Million in Boeing Stock Ahead of Reported China Deal Indian Markets Open Flat After Monday Rally Crude Oil Surges on USIran Tensions SK Hynix Crosses 1 Trillion Market Cap as AI Boom Fuels Chip Rally Sensex Stocks with up to 40 Upside Potential Analysts Identify Key Names Paul Tudor Jones Sees No Chance Kevin Warsh Could Persuade Fed to Cut Rates MTX Q1 2026 Earnings EPS Surprises to the Upside as Earnings Beat Estimates OXLCN Q4 2025 Earnings EPS Misses Estimates Amid Stable Preferred Distribution AEye Inc Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Absent GPN Q1 2026 Earnings EPS Surpasses Estimates with 366 Surprise OLPX Q1 2026 Earnings EPS Surprises Sharply to the Upside Amidst Operational Efficiency Greenwich LifeSciences GLSI Slips 094 as Stock Hovers Near Key Support Murano Global Investments MRNO Nears Key Support After 5 Slide Cohen Steers Infrastructure Fund UTF Edges Higher as Infrastructure Demand Remains Steady Definium Therapeutics DFTX Gains on Strength Approaching Key Resistance